Denise L. Johnson Miller, MD, FACS


Medical Director, Breast Surgery
Hackensack Meridian Health Cancer Care of Monmouth and Ocean Counties
19 Davis Ave, 1st Floor Women’s Cancer Center
Neptune, NJ 07753, USA

Biography

Education

• (1972-1976) Undergraduate and Professional, Northwestern University, Six Year Honors Medical Program BS Medical Science
• (1976-1978) Graduate and Professional, Washington University, School of Medicine

Research Interest

Research interests include: Molecular residual disease detection in cancer patients cell free tumor DNA, Breast cancer TRNBC subtypes.

Scientific Activities

Honors and Awards

• (1978-1979) Best Surgical Intern, Jewish Hospital of St. Louis
• (1983-1984) American Cancer Society Resident Research Fellowship
• (1992) Governor Competitive Appointment, Department of Health, Selected as One of Six Outstanding Women in Veterans Health
• (1995-1998) Sterling’s Honorarium and Who’s Who
• (1996-1997) Stanford University Dean’s Fellowship Award
• (1997) AACR Minority Scholar Award, Sponsored Vanessa Brown PGY-2
• (1997, 1999, 2001, 2003, 2004, 2007) Kaiser Faculty Teaching Award Nominations, Top Ten List of Teachers at Stanford
• (1994) Katherine McCormick–Travel Award
• (1998) St. Clair Drake Teaching Award, Stanford University-Wide (faculty vote)
• (1999) Franklin O. Ebaugh Award for Medical Student Advising, Stanford University Medical School (student and faculty vote)
• (1999) Minority Medical Faculty Achievement Recognition, Stanford University
• (2000) Graduate Student Women of Color Faculty Recognition Award Stanford University
• (2002) Selected for National Medical Leadership in Education Award, Inaugural Award
• (2004) Stanford University School of Medicine Advising Dean’s “Excellence in Teaching”( faculty and student vote selection)
• (2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2014, 2015, 2016, 2017-2020) American’s Top Doctors for Cancer, Selected by Castle Connolly Medical Ltd.
• (2009, 2011) Biltmore’s Who’s Who Registry of Executives and Professionals Honored Member
• (2010, 2011) Indianapolis Top Doctor Breast Surgery
• (2011, 2014, 2015) US News and World Report Top 1% Breast Surgery Physician
• (2011) American Institute Geriatric: American Board of Cardiology Honored Special National Recognition in Geriatric Oncology
• (2013, 2014 , 2015, 2016, 2017, 2018, 2019 October ISSUES) Inside New Jersey Top Doctor in Breast Surgery
• (2014, 2015, 2016, 2017, 2018, 2019) Inside New Jersey Top Doctor for Women in Surgery
• (2014, 2015, 2016, 2017-2019) Inside New Jersey, Top Doctors for Surgery and Top Doctors for Cancer
• (2014, 2015, 2016, 2017, 2018, 2019, 2020) Top Doctor in New York Metropolitan Area Breast Surgery
• (Spring 2014) Featured article Meridian Breast Surgery-Dr. Camal/Dr. Johnson Miller

Publications

1. Johnson DL, Kettman J. Accessory Cell Restrictions on In-vitro Growth of a T-cell Lymphoma: In Symposium on B- and T-cell Lymphomas. Vitteta E, ed. NY, USA: Acedemic Press; 1982: 301-305.
2. Cosman BC, Sullivan GHJ, Johnson DL, Perkash I. Gastrostomy for gaseous decompression in a quadriplegic man. Paraplegia. 1990; 12: 300-312.
3. Banks WA, Kastin AS, RadulovicS, Johnson, DL, Conley FK, Schally AV. Selective uptake of the somatostatin analog, RC-160 across the blood-brain tumor barrier of mice with KHT sarcomas. Anticancer Drugs. 1992; 3: 519-523. doi: 10.1097/00001813-199210000-00012
4. Johnson DL, Lipsett J, Wagman L, Terz JJ. Primary treatment of anal canal cancer. (lead article). SG&O. 1993; 192: 500-506.
5. Hase K, Shatney CH, Johnson DL, Trollope M, Vierra M.. Prognostic value of tumor ‘budding’ in patients with colorectal cancer. Dis Colon Rectum. 1993; 36: 627-635. doi: 10.1007/BF02238588
6. Johnson DL, Lang E. Technical aspects of non-operative dilation of a complex colon anastomotic stricture. Dig Dis Sci. 1993; 38(10): 1929-1932. doi: 10.1007/BF01296121
7. Jardines L, O’Donnell M, Johnson DL, Terz JJ, Forman S. Acalculous cholecystitis in bone marrow transplant patients. Cancer. 1993; 71: 354-358. doi: 10.1002/1097-0142(19930115)71:2<354::aid-cncr2820710214>3.0.co;2-l
8. Tsutaoka B, Hansen J, Johnson DL, Holdoniy M. Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile. Clin Infect Dis. 1994; 18: 982-984. doi: 10.1093/clinids/18.6.982
9. Hase K, Shatney CH, Johnson DL, Trollope M, VierraM. Long term results of curative resection of minimally invasive “early” colorectal cancer. Dis Colon Rectum. 1995; 38(1): 19-26. doi: 10.1007/BF02053852
10. Morris J, Johnson DL, Rimmer JP, Kuo P, Alfrey EJ, Bastidas A, et al. Identical-twin small bowel transplant for desmoid tumor. Lancet. 1995; 345: 1577-1578. doi: 10.1016/s0140-6736(95)91130-8
11. Kuo PC, Morris J, Marks WH, Lieberman JM, Johnson DL, Alfrey EJ, et al. Human Syngeneic intestinal transplantation: Evaluation of enterocyte viability with serum levels of intestinal fatty acid binding protein. Clin Transplant. 1996; 10(3): 282-286.
12. Morris JA, Johnson DL, Rimmer JP, Kuo PC, Alfrey EJ, Bastidas JA, et al. Identical twin small bowel transplant after resection of abdominal desmoid tumor. Transplantation. 1996; 28: 2709-2710.
13. Kuo PC, Marks WH, Lieberman JM, Johnson DL, Alfrey EJ, Dafoe DC. Systemic inflammatory response syndrome after human syngeneic intestinal transplantation: Evidence for disruption of enterocyte barrier function. Transplant Proc. 1996; (5): 2763-2764.
14. Morris JA, Johnson DL, Rimmer JA, Kuo PC, Alfrey EJ, Bastidas JA, et al. Identical twin small bowel transplant after resection of abdominal desmoid tumor. Transplant Proc. 1996; 28(5): 2731-2732.
15. Yokoyama S, Shatney CH, Mochizuki H, HaseK, Johnson DL, Cummings S, Trollope et al. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer. Am Surg. 1997; 63: 243-247.
16. Jadvar H, Segal GM, Johnson DL. Clinical applications and cost-effectiveness of PET in melanoma. Proc Int PET Ann Conf. 1997; 11-12.
17. Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, et al. Functional and phenotypic characterization of an endogenous T–cell response against melanoma. Nat Med. 1999; 5: 677-685.
18. Pace WM, Johnson DL, McDougall IR. SPECT imaging in melanoma lymphoscintography. Eur J Nucl Med. 1999; 26(suppl): S64.
19. Pace WM, Johnson DL, McDougall IR. Improved imaging techniques for melanoma lymphoscintography. Clin Nucl Med. 1999; 24(suppl): 295.
20. Jadvar H, Johnson DL, Segall G. The effect of fluorine–18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma. Clin Nucl Med. 2000; 25(1): 48-51. doi: 10.1097/00003072-200001000-00011
21. Sze DY, O’Sullivan GJ, Johnson DL, Dake MD. Mesenteric and portal venous thrombosis treated by transjugular mechanical thrombolysis. AJR Am J Roentgenol. 2000; 175(3): 732-734. doi: 10.2214/ajr.175.3.1750732
22. Swetter SM, Carroll LA, Johnson DL, Segall GM. Position emission tomography (PET) is superior to computerized tomography (CT) for metastatic staging in melanoma patients. Clin Positron Imaging. 2000; 3(4): 154.
23. Kinoshita M, Johnson DL, Shatney CH, Lee YL, Mochizuki H: Cancer cells surviving hypoxia obtain hypoxia resistance and maintain anti-apoptotic potential under reoxygenation. Int J Cancer. 2001; 91(3): 322-326.
24. Swetter SM, Carroll LA, Johnson DL, Segall GM. Positron emission tomography (PET) is superior to computerized tomography (CT) for metastatic detection in melanoma patients. Ann Surg Oncol. 2002; 9(7): 646-653. doi: 10.1007/BF02574480
25. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature. 2010; 466(7302:) 133-137.
26. Tagawa ST, Lee P, Snively J, Boswell W, Ounpraseuth S, Lee S, et al. Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma. Cancer. 2003; 98(1): 144-154. d oi: 10.1002/cncr.11462
27. Daniel BL, Gardner RW, Birdwell RL, Nowels KW, Johnson DL. Magnetic resonance imaging of intraductal papilloma of the breast. Magn Reson Imaging. 2003; 21(8): 887-892. doi: 10.1016/s0730-725x(03)00192-9
28. Swetter SM, Ecker PM, Johnson DL, Harvell JD. Primary dermal melanoma: A distinct subtype of melanoma. Arch of Derm. 2004; 140(1): 99-103. doi: 10.1001/archderm.140.1.99
29. Berk DR, Johnson DL, Uzieblo A, Kiernan M, SwetterSM. Sentinel lymph node biopsy for cutaneous melanomas. Arch Dermatol. 1997-2004; 141(8): 1016-1022.
30. Kohrt HE, Olsten RA, Bermas HR, Goodson WH, Wood DJ, Henry S, et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer. 2008; 8: 66. doi: 10.1186/1471-2407-88-66
31. Tsai EY, Taur A, Espinosa L, Quon A, Johnson D, Dick S, et al. Staging accuracy in mycosis fungoides/Sezary syndrome using integrated positron emission tomography and computer tomography. Arch Dermatol. 2006; 142(5): 577-584. doi: 10.1001/archderm.142.5.577
32. Shuka A, Johnson D, Bibby J. Impact of patient position on filling phase of urodynamics in women. Int Urogynecol J Pevic Floor Dysfunct. 2006; 17(3): 231-233. doi: 10.1007/s00192-005-1350-1351
33. Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med. 2005; 2(9): e284.
34. Muller CB, Rise SM, Fouke J, Whitney T, Denton DD, Cantor N, et al. Gender difference and performance in science. Science. 2005; 307(5712): 1043. doi: 10.1126/science.307.5712.1043b
35. Franc BL, Mari C, Johnson D, Leong SP. The role of a positron-and high-energy gamma photon probe in intraoperative localization of recurrent melanoma. Clin Nucl Med. 2005; 30(12): 787-791. doi: 10.1097/01.rlu.0000186856.86505.96
36. Iagaru A, Quon A, Johnson D, Gambhir SS, McDougall IR. 2 Deoxy-2(F-18) Fluoro-D.glucose positron emission tomography/computed tomography in the management of melanoma. Mol Imaging Biol. 2007; 9(1): 50-57. doi: 10.1007/s11307-006-0065-0
37. Tu WH, Johnson DL, Gill H. Melanoma of the penis with scientigraphically guided sentinel node biopsy. Indian J Urol. 2010; 26(3): 429-430. doi: 10.4103/0970-1591.70587
38. Crichtley-Thorne R, Simons DL, Yan N, Miyahira A, Dirbas F, Johnson DL, et al. Impaired intereron signaling is a common immune defect in human cancer. Proc Natl Acad Sci U S A. 2009; 106(22): 9010-9015. doi: 10.1073/pnas.0901329106
39. Berk DR, LaBuz E, Johnson DL, Dadras S, Swetter S. Melanoma and melanocytic tumors of uncertain malignant potential. The Stanford Experience 1995-2008. Pediatr Dermatol. 2010; 27(3): 244-254; doi: 10.1111/j.1525-1470.2009.01078.x
40. Yu H, Simons DL, Segall I, Carcamo-Cavazos V, Schwartz EJ, Yan N, et al. PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ. PLoS One. 2012; 7(12): e51239. doi: 10.1371/journal.pone.0051239
41. Zuckerman NS, Yu H, Simons DL, Bhattacharya N, Carcamo-Cavazos V, Yan N, et al. Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients. Int J Cancer. 2013; 132(11): 2537-247. doi: 10.1002/ijc.27933
42. Kaveh AH, Seminara NM, Barnes MA, Berger AJ, Chen FW, Johnson D, et al. Aberrant lymphatic drainage as risk for melanoma recurrence after negative sentinel node biopsy in middle aged and older men. Head Neck. 2015; 38 Suppl 1: E754-E760. doi: 10 1002/jed/24094
43. Biswal A, Erler J, Qari O, Gupta V, Hossain M, Asif A, et al. The effect of the eighth edition breast cancer staging system on 100 consectutive patients. Journal of General Internal Medicine. 2019; 11(6): 407-414. doi: 10.14740/jocmr3803
44. Matinbo D, Scott O, McKenzie T, Shingala P, Lachica M, Topilow A, et al. To scan or not to scan: An evaluation of preoperative MRI use in primary breast cancer. Breast Cancer. 2020.
45. General and Laparoscopic Surgery News. World’s First Reported Successful Identical Twin Small Bowel Transplant. 1995.
46. General Surgery News. Mutant p53 Linked to Decreased Survival in Colorectal Cancer. 1998.
47. Physician’s Weekly. Colorectal Cancer. “Increased p53 spells poor prognosis”. 15: 38.
48. San Jose Mercury News. “Gene Tests Promising; Flawed” by April Lynch. 2004.
49. Mammograms: Barriers to Breast Cancer Screening among Poor, Rural Women. Web site. USNews.com. 2004.